Senseonics Holdings Inc (Senseonics) is a medical technology company that designs, develops and commercializes glucose monitoring systems to improve the lives of patients with diabetes. It offers a continuous glucose monitoring system, sensor, smart transmitter and data management system. The company's product portfolio comprises eversense, eversense XL and eversense E3 CGM systems. It’s sensor utilizes a patented fluorescent, glucose-indicating polymer technology to measure glucose in the interstitial fluid. The company's data management system is a browser-based application that enables to upload glucose readings from the mobile app. Senseonics is headquartered in Germantown, Maryland, the US.
Headquarters
United States of America
Address
20451 Seneca Meadows Pkwy, Germantown, Maryland, 20876-7005
Website
www.senseonics.com
Telephone
1 301 5157260
No of Employees
121
Industry
Medical Equipment
Ticker Symbol & Exchange
SENS (AFM)
Revenue (2022)
$16.4M
19.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
147%
(2022 vs 2021)
Market Cap*
$229.8M
Net Profit Margin (2022)
XYZ
139.2%
(2022 vs 2021)
* As of and is in US$
Senseonics Holdings Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Smart Transmitter | Service: | Eversense |
| Sensor | Mobile Application | |
| Eversense | ||
| XYZ | ||
| XYZ | ||
| XYZ |
Competitor Comparison
| Key Parameters | Senseonics Holdings Inc | Abbott Laboratories | Becton Dickinson and Co | DexCom Inc | Abbott Diabetes Care Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Germantown | Abbott Park | Franklin Lakes | San Diego | Indianapolis |
| State/Province | Maryland | Illinois | New Jersey | California | Indiana |
| No. of Employees | 121 | 115,000 | 77,000 | 7,500 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Stephen P. DeFalco | Chairman | Executive Board | 2015 | 62 |
| Timothy T. Goodnow | Chief Executive Officer; Director; President | Executive Board | 2015 | 61 |
| Francine R. Kaufman | Chief Medical Officer; Director | Executive Board | 2019 | 72 |
| Frederick Sullivan | Chief Financial Officer; Secretary | Senior Management | 2022 | 39 |
| Mukul Jain | Chief Operating Officer | Senior Management | 2017 | 50 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer